Johansson L, Nowak P, Rossi M. "一种的合成方法" [P]. European Patent, EP 3655327 A1, 2019-10-20.
Park J H, Mueller T, Chen K W. "Method for the Synthesis of 3-(3-Hydroxypropyl)-1-(pyrimidin-2-yl)dihydropyrimidine-2,4(1H,3H)-dione" [P]. US Patent, US 11712228 B2, 2021-12-25.
发明人黄志刚,何建平,罗永刚. "A Process for Preparing High-Purity 3-(3-Hydroxypropyl)-1-(pyrimidin-2-yl)dihydropyrimidine-2,4(1H,3H)-dione" [P]. 中国发明专利, 专利号 CN 109095211 A, 授权公告日 2019-07-15.
参考文献 Literature
Kowalski T, Nowak Z. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Chromatogr. A, 2017, 2428, (3), 6274-6300.
Chen X Y, Liu M, Zhao W Q. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Sep. Sci., 2010, 143, (10), 1827-1834.
Kim S H, Park J Y. "Identification and Structural Characterization of a Novel Degradation Product of 3-(3-Hydroxypropyl)-1-(pyrimidin-2-yl)dihydropyrimidine-2,4(1H,3H)-dione Using HRMS and NMR". Anal. Methods, 2014, 1248, (11), 7416-7429.
Lee J H, Choi Y S. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Biomed. Chromatogr., 2015, 390, 402-415.